Joshua Hare Purchases 106,383 Shares of Longeveron Inc. (NASDAQ:LGVN) Stock

Longeveron Inc. (NASDAQ:LGVN) insider Joshua Hare acquired 106,383 shares of Longeveron stock in a transaction on Wednesday, April 10th. The shares were bought at an average cost of $2.35 per share, for a total transaction of $250,000.05. Following the completion of the transaction, the insider now owns 590,727 shares in the company, valued at approximately $1,388,208.45. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Longeveron Stock Down 16.3 %

Shares of Longeveron stock opened at $1.69 on Friday. The company has a current ratio of 1.50, a quick ratio of 1.50 and a debt-to-equity ratio of 0.21. The company’s fifty day simple moving average is $4.32 and its two-hundred day simple moving average is $12.35. The company has a market cap of $4.25 million, a P/E ratio of -0.17 and a beta of 0.21. Longeveron Inc. has a 12-month low of $1.62 and a 12-month high of $44.00.

Longeveron (NASDAQ:LGVN) last issued its quarterly earnings data on Tuesday, February 27th. The company reported ($2.50) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($2.10) by ($0.40). The company had revenue of $0.06 million for the quarter, compared to analysts’ expectations of $0.21 million. Longeveron had a negative net margin of 3,020.17% and a negative return on equity of 209.14%. Research analysts anticipate that Longeveron Inc. will post -8.5 EPS for the current year.

Institutional Trading of Longeveron

A number of hedge funds and other institutional investors have recently modified their holdings of LGVN. Citadel Advisors LLC purchased a new stake in shares of Longeveron in the 4th quarter worth about $44,000. Northern Trust Corp purchased a new stake in shares of Longeveron in the 2nd quarter worth about $63,000. State Street Corp purchased a new stake in shares of Longeveron in the 2nd quarter worth about $88,000. Geode Capital Management LLC grew its position in shares of Longeveron by 78.6% in the 2nd quarter. Geode Capital Management LLC now owns 66,392 shares of the company’s stock worth $224,000 after buying an additional 29,212 shares during the period. Finally, Boothbay Fund Management LLC purchased a new stake in shares of Longeveron in the 2nd quarter worth about $254,000. 10.01% of the stock is owned by hedge funds and other institutional investors.

About Longeveron

Longeveron Inc, a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young, healthy adult donors.